KUNAL BUCH

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology LAWRENCEVILLE, GA NPI 1124373196

General Payments — all program years on this page

$511.37

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 32
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $98.22 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Education $67.1811
Food and Beverage $31.042

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Retrophin, Inc. $75.9412
Acerta Pharma LLC $22.281

By program year

Program yearAmountRecords
2018 $132.038
2019 $69.364
2022 $23.301
2023 $188.466
2024 $98.2213

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105630735 AstraZeneca Pharmaceuticals LP $22.28 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149929303 Travere Therapeutics, Inc. $0.37 05/20/2024 Education Undisputed 01/23/2026 View at CMS
1149929307 Travere Therapeutics, Inc. $0.37 07/08/2024 Education Undisputed 01/23/2026 View at CMS
1149929311 Travere Therapeutics, Inc. $0.37 08/19/2024 Education Undisputed 01/23/2026 View at CMS
1149929315 Travere Therapeutics, Inc. $3.08 03/12/2024 Education Undisputed 01/23/2026 View at CMS
1149929319 Travere Therapeutics, Inc. $3.08 04/15/2024 Education Undisputed 01/23/2026 View at CMS
1149929323 Travere Therapeutics, Inc. $3.08 05/20/2024 Education Undisputed 01/23/2026 View at CMS
1149929326 Travere Therapeutics, Inc. $3.08 07/08/2024 Education Undisputed 01/23/2026 View at CMS
1149929330 Travere Therapeutics, Inc. $3.08 08/19/2024 Education Undisputed 01/23/2026 View at CMS
1149929334 Travere Therapeutics, Inc. $8.76 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149929338 Travere Therapeutics, Inc. $16.89 03/12/2024 Education Undisputed 01/23/2026 View at CMS
1149929342 Travere Therapeutics, Inc. $16.89 04/15/2024 Education Undisputed 01/23/2026 View at CMS
1149929346 Travere Therapeutics, Inc. $16.89 05/20/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.